Norio Shiba
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.
Journal: British journal of haematology
Published: March 25, 2026
Feasibility and Safety of Somato-Cognitive Coordination Therapy for Cerebellar Ataxia Following Pediatric Brain Tumor Treatment.
Journal: Pediatric blood & cancer
Published: February 28, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.
Journal: Leukemia
Published: November 01, 2025
Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).
Journal: British journal of haematology
Published: September 12, 2025
Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia.
Journal: Haematologica
Published: December 24, 2024
Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities.
Journal: International journal of hematology
Published: September 04, 2024
Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Journal: Haematologica
Published: July 08, 2024
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.
Journal: Leukemia
Published: March 19, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Journal: Pediatric blood & cancer
Published: January 15, 2024
Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.
Journal: Science advances
Published: December 13, 2023
Last Updated: 09/26/2026